Masashi Ito

2.4k total citations
112 papers, 1.7k citations indexed

About

Masashi Ito is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Masashi Ito has authored 112 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 24 papers in Molecular Biology and 20 papers in Surgery. Recurrent topics in Masashi Ito's work include Mycobacterium research and diagnosis (11 papers), Cystic Fibrosis Research Advances (9 papers) and Tuberculosis Research and Epidemiology (9 papers). Masashi Ito is often cited by papers focused on Mycobacterium research and diagnosis (11 papers), Cystic Fibrosis Research Advances (9 papers) and Tuberculosis Research and Epidemiology (9 papers). Masashi Ito collaborates with scholars based in Japan, Hungary and United Kingdom. Masashi Ito's co-authors include Yoshio Mishima, Kenichi Sugihara, Masaharu Murakami, Noriharu Ae, Tomohito Arao, Tatsuo Sato, Zenro Nihei, Touichirou Takizawa, Keita Koseki and Kazuhíko Ishihara and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Science & Technology and Applied Physics Letters.

In The Last Decade

Masashi Ito

97 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masashi Ito Japan 24 418 399 385 203 195 112 1.7k
Kenichiro Asano Japan 20 357 0.9× 174 0.4× 344 0.9× 92 0.5× 83 0.4× 81 1.9k
Tomomi Fujii Japan 30 1.2k 2.9× 543 1.4× 411 1.1× 114 0.6× 99 0.5× 182 2.7k
Xiaozhen Wang China 22 377 0.9× 317 0.8× 201 0.5× 31 0.2× 140 0.7× 120 2.0k
Isabelle R. Miousse United States 24 809 1.9× 248 0.6× 84 0.2× 84 0.4× 120 0.6× 61 1.8k
Balamurugan Vellayappan Singapore 21 874 2.1× 738 1.8× 527 1.4× 36 0.2× 90 0.5× 93 2.8k
Takahiro Kobayashi Japan 17 262 0.6× 152 0.4× 163 0.4× 114 0.6× 37 0.2× 135 1.3k
Liang Zhang China 25 820 2.0× 466 1.2× 153 0.4× 77 0.4× 98 0.5× 170 2.3k
Zhijian Chen China 21 268 0.6× 107 0.3× 100 0.3× 131 0.6× 57 0.3× 66 1.2k
Takahiro Ishikawa Japan 23 587 1.4× 148 0.4× 112 0.3× 12 0.1× 211 1.1× 136 1.8k

Countries citing papers authored by Masashi Ito

Since Specialization
Citations

This map shows the geographic impact of Masashi Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Ito more than expected).

Fields of papers citing papers by Masashi Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Ito. The network helps show where Masashi Ito may publish in the future.

Co-authorship network of co-authors of Masashi Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Ito. A scholar is included among the top collaborators of Masashi Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Ito. Masashi Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kodama, Tatsuya, Akio Aono, Keiji Fujiwara, et al.. (2025). Risk factors, molecular analysis and treatment outcomes of amikacin-resistant Mycobacterium avium complex pulmonary disease. ERJ Open Research. 11(4). 1084–2024.
2.
Ito, Masashi, et al.. (2025). Severe bronchiectasis and chronic rhinosinusitis due to homozygous WFDC2 Variants: The first three cases reported from Japan. Respiratory Medicine Case Reports. 55. 102214–102214.
3.
Hijikata, Minako, et al.. (2025). Robust detection of pathogenic HYDIN variants that cause primary ciliary dyskinesia using RNA-seq of nasal mucosa. Journal of Medical Genetics. 62(3). 180–184.
4.
Ito, Masashi, Koji Furuuchi, Keiji Fujiwara, et al.. (2024). Epidemiological trends and clinical relevance of nontuberculous mycobacterial pulmonary disease in a referral hospital in Japan, 2017–2021. Respiratory Investigation. 62(6). 1064–1071.
5.
Nakagawa, Natsuki, et al.. (2024). Efficacy and safety of long-term macrolide therapy for non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis. Respiratory Investigation. 62(6). 1079–1087. 3 indexed citations
6.
Fujiwara, Keiji, Koji Furuuchi, Masashi Ito, et al.. (2024). Beyond Symptoms: Radiologic identification of asymptomatic Mycobacterium avium complex pulmonary infections. Respiratory Medicine. 226. 107627–107627. 2 indexed citations
7.
Fujiwara, Keiji, et al.. (2024). Clofazimine serum concentration and safety/efficacy in nontuberculous mycobacterial pulmonary disease treatment. Respiratory Medicine. 231. 107718–107718. 4 indexed citations
8.
9.
10.
Ito, Masashi, Koji Furuuchi, Keiji Fujiwara, et al.. (2023). Multiple bacterial culture positivity reflects the severity and prognosis as bronchiectasis in Mycobacterium avium complex pulmonary disease. Respiratory Medicine. 219. 107417–107417. 3 indexed citations
11.
Yamazaki, Kazuto, Kenji Kubara, Yuta Suzuki, et al.. (2023). Multivalent mannose-conjugated siRNA causes robust gene silencing in pancreatic macrophages in vivo. European Journal of Pharmaceutics and Biopharmaceutics. 183. 61–73. 9 indexed citations
12.
Ito, Masashi, et al.. (2023). Dapagliflozin induced hypernatremia via osmotic diuresis: a case report. CEN Case Reports. 13(1). 9–13. 1 indexed citations
13.
Ito, Masashi, et al.. (2023). <i>FOXJ1</i> Variants Causing Primary Ciliary Dyskinesia with Hydrocephalus: A Case Report from Japan. Internal Medicine. 63(10). 1433–1437. 3 indexed citations
14.
Morimoto, Kozo, Kazuro Iwai, Takashi Yoshiyama, et al.. (2022). Epidemiological characteristics of nontuberculous mycobacteriosis and bronchiectasis: comparative study using national mortality statistics from 1970 to 2015 in Japan. ERJ Open Research. 9(1). 424–2022. 4 indexed citations
15.
Imaizumi, Yoichi, Michiko SUGAWARA, Takefumi Sone, et al.. (2018). T-type Calcium Channels Determine the Vulnerability of Dopaminergic Neurons to Mitochondrial Stress in Familial Parkinson Disease. Stem Cell Reports. 11(5). 1171–1184. 64 indexed citations
16.
Kuroda, Takayuki, Mitsuru Notoya, Masashi Ito, et al.. (2012). Renoprotective Action of a Matrix Metalloproteinase Inhibitor in Progressive Mesangioproliferative Nephritis. SHILAP Revista de lepidopterología. 2(1). 133–146. 1 indexed citations
17.
Koseki, Keita, Touichirou Takizawa, Morio Koike, et al.. (2000). Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer. 89(4). 724–732. 16 indexed citations
18.
Koseki, Keita, Touichirou Takizawa, Morio Koike, et al.. (2000). Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer. 89(4). 724–732. 116 indexed citations
19.
Ito, Masashi, et al.. (1985). Development and evaluation of statistical prediction model for photochemical smog. Journal of Japan Society of Air Pollution. 20(1). 33–39. 1 indexed citations
20.
Ito, Masashi, et al.. (1960). Studies on pertussal toxin. Nippon Saikingaku Zasshi. 15(7). 655–660. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenichiro Asano Breakdown of academic impact, for papers by Tomomi Fujii Breakdown of academic impact, for papers by Xiaozhen Wang Breakdown of academic impact, for papers by Isabelle R. Miousse Breakdown of academic impact, for papers by Balamurugan Vellayappan Breakdown of academic impact, for papers by Takahiro Kobayashi Breakdown of academic impact, for papers by Liang Zhang Breakdown of academic impact, for papers by Zhijian Chen Breakdown of academic impact, for papers by Takahiro Ishikawa
Rankless by CCL
2026